AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 193.50
-9.00 (-4.44%)
Apr 17, 2026, 1:55 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 16.69 billion as of April 17, 2026. Its market cap has increased by 256.99% in one year.
Market Cap
16.69B
Enterprise Value
15.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
193.50
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 16.69B, an increase of 227.47%. That is a compound annual growth rate of 53.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 16.69B | 8.92% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 26.07B |
| Lumosa Therapeutics | 21.94B |
| Sunmax Biotechnology | 21.65B |
| Polaris Group | 16.17B |
| Medigen Vaccine Biologics | 15.78B |
| EirGenix | 15.31B |
| TaiMed Biologics | 14.56B |
| Ever Supreme Bio Technology | 12.26B |